Pyridoxine, DOPA, and Parkinsonism.
D000284:Administration, Oral; D002986:Clinical Trials as Topic; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000097:blood / Q000627:therapeutic use*; D004336:Drug Antagonism; D004347:Drug Interactions; D005069:Evaluation Studies as Topic; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*; D010648:Phenylacetates / Q000097:blood; D011732:Pyridoxal Phosphate / Q000097:blood; D011736:Pyridoxine / Q000008:administration & dosage / Q000627:therapeutic use*; D026681:Vitamin B 6 Deficiency / Q000378:metabolism
D010648:Phenylacetates; D011732:Pyridoxal Phosphate; D004295:Dihydroxyphenylalanine; D011736:Pyridoxine